2020
A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.
Psutka S, Gulati R, Jewett M, Fadaak K, Finelli A, Morgan T, Pierorazio P, Allaf M, Herrin J, Lohse C, Thompson R, Boorjian S, Atwell T, Schmit G, Costello B, Legere L, Shah N, Leibovich B. A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity. Journal Of Clinical Oncology 2020, 38: 610-610. DOI: 10.1200/jco.2020.38.6_suppl.610.Peer-Reviewed Original ResearchCancer-specific mortalityRenal cortical massesCharlson Comorbidity IndexPerformance statusActive surveillancePersonalized treatment selectionCortical massTreatment selectionThermal ablationContemporary multi-institutional cohortTreatment-specific probabilitiesECOG performance statusTreatment-associated complicationsMulti-institutional cohortCause of deathClinical decision aidCause of mortalityCause mortalityComorbidity indexEligible patientsPatient characteristicsComplication ratePatient ageRadiological featuresComplication risk
2019
Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age
Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND. Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age. Clinical Gastroenterology And Hepatology 2019, 18: 337-346.e19. PMID: 31108228, PMCID: PMC7386161, DOI: 10.1016/j.cgh.2019.05.017.Peer-Reviewed Original ResearchConceptsGastrointestinal bleedingAntiplatelet monotherapyGIB riskAntiplatelet agentsRisk of GIBCombination antithrombotic therapyDifferent antithrombotic regimensDifferent antithrombotic strategiesDrug exposure categoriesProportion of patientsNationwide claims dataMedicare Advantage enrolleesAntithrombotic regimensBleeding increasesAntithrombotic therapyAntithrombotic strategiesElderly patientsCombination regimensPatient ageCombination therapyPrimary diagnosisAntithrombotic drugsAntithrombotic agentsCardiovascular conditionsRetrospective analysis
2017
Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events
McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events. Journal Of General Internal Medicine 2017, 32: 1097-1105. PMID: 28685482, PMCID: PMC5602759, DOI: 10.1007/s11606-017-4095-x.Peer-Reviewed Original ResearchConceptsDiabetes Complications Severity IndexSevere dysglycemiaIndex hospitalizationMedicare Advantage beneficiariesRisk factorsBetter care transitionsComplications Severity IndexPost-discharge managementIndependent risk factorYounger patient ageOptumLabs Data WarehouseStrong risk factorYears of ageBackgroundHospital readmissionsDesignRetrospective analysisCause readmissionUnplanned readmissionPatient agePrior hospitalizationReadmission ratesYounger patientsHeart failureHospital readmissionSevere hypoglycemiaDiabetes complications
2012
The Effectiveness of Implementing an Electronic Health Record on Diabetes Care and Outcomes
Herrin J, da Graca B, Nicewander D, Fullerton C, Aponte P, Stanek G, Cowling T, Collinsworth A, Fleming NS, Ballard DJ. The Effectiveness of Implementing an Electronic Health Record on Diabetes Care and Outcomes. Health Services Research 2012, 47: 1522-1540. PMID: 22250953, PMCID: PMC3401397, DOI: 10.1111/j.1475-6773.2011.01370.x.Peer-Reviewed Original ResearchConceptsPrimary care practicesBlood pressureDiabetes careOptimal careCare practicesDiastolic blood pressureSystolic blood pressureYears of ageElectronic health record implementationElectronic health recordsAspirin prescriptionUnexposed patientsAspirin useCare bundleInsulin usePatient ageLipid controlPrimary outcomeClinical outcomesLDL cholesterolSmoking cessationChart auditDiabetes measuresDiabetes patientsPatients